NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cance... (on to the webcast at least fifteen minut...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients

Date:12/12/2010

on to the webcast at least fifteen minutes prior to the scheduled start time. A replay of this investor event will be available on the Nektar website approximately three hours after the presentation and will be archived for four weeks.

Figure A: Efficacy Table: Objective Tumor Response Rate by RECIST (Investigator Assessment)Response by RECIST v 1.0

NKTR-102

145 mg/m²

q14d

ITT/Evaluable

NKTR-102

145 mg/m²

q21d ITT/EvaluableTOTAL

ITT/EvaluableN

35/31*

35

70/66ORR (confirmed + unconfirmed

11 (31%)/11 (35%)

11 (31%)

22 (31%)/22 (33%)ORR (confirmed)

10 (29%)/10 (32%)

9 (26%)

19 (27%)/19 (29%)CR (confirmed)

2 (6%)/2 (7%)

0

2 (3%)/2 (3%)PR (confirmed)

8 (23%)/8 (26%)

9 (26%)

17 (24%)/17 (26%)SD

17 (48%)/13 (42%)

17 (48%)

34 (49%)/30 (45%)PD

8 (23%)/8 (26%)

9 (26%)

17 (24%)/17 (26%)Clinical benefit

(CR+PR+SD greater than or equal to 6 months)

12 (34%)/12 (39%)

15 (43%)

27 (38%)/27 (41%)*4 patients in the Q14 day arm with no post-baseline scans, but no evidence of progression were excluded from analysis in the evaluable population.Figure B: Efficacy Table: Response rate by prior therapyPrior Therapy Subgroup

Response by RECIST v 1.0

Evaluable PatientsNKTR-102

145 mg/m²

q14d

N=31

NKTR-102

145 mg/m²

q21d

N=35TOTALPrior A/T only

ORR (confirmed)

7/22 (32%) 5/21 (24%)12/43 (28%)Prior A/T in MBC

ORR (confirmed)

2/6 (33%)

2/8 (25%)

4/14 (29%)Prior A/T/C

ORR (confirmed)

2/6 (33%)

3/9 (33%)5/15 (33%)Figure C: Efficacy Table: Response rate by tumor characteristicsDisease Subgroup

Response by RECIST v 1.0

Evaluable PatientsNKTR-102

145 mg/m²

q14d

N=31
<
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine technology :

1. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
2. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
3. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
4. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
5. Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
6. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
7. NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma
10. Halozymes rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
11. Pevions Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase I Clinical Study

Post Your Comments:

(Date:5/23/2013)... , May 23, 2013 The need to ... treatment continuum was highlighted prominently at the 108 ... Association (AUA), in San Diego. According to SonaCare ... focused ultrasound (HIFU) technology, the need for image-guided ... for urologists to consider minimally invasive ablative treatments, ...

(Date:5/23/2013)... 2013 Every day, their baby stopped breathing, his collapsed ... April and Bryan Gionfriddo watched helplessly, ... "Quite a few doctors said he had a good ... April Gionfriddo , about her now 20-month-old son, Kaiba. ... we would take it and run with it." ...

(Date:5/23/2013)... Mass. , May 23, 2013 Hologic, ... HOLX ), a leading developer, manufacturer and supplier ... products, with an emphasis on serving the healthcare ... large-scale observational study in a U.S. clinical practice ... technology (breast tomosynthesis) with conventional 2D mammography alone ...

Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6 Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2 Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3 Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4

[0] Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting [0] Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing [0] First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection

... (Nasdaq: LMNX ) announced today that management ... Stanley Global Healthcare Conference and the UBS Global Life ... York City. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... executive officer, will present at the Morgan Stanley Global ...

... H&P Industries, Inc., a manufacturer of OTC drug products ... the Chief Operating Officer,s (COO) role. ... Pharmaceutical and Biotechnology field to H&P mostly with Abbott ... and Validations to H&P as they begin to restart ...

Cached Medicine Technology:Luminex Corporation to Present at Upcoming Investment Conferences In September 2

Luminex Corporation to Present at Upcoming Investment Conferences In September H&P/TRIAD Hires Chief Operating Officer

(Date:5/25/2013)... Mansfield, MA (PRWEB) May 25, 2013 Imagine ... long -- the energy loss, hot air and wasted energy! ... whole house fan, a fireplace or clothes dryer, that may ... , Drafts from these often overlooked holes waste energy in ... source of heating and cooling loss in the home. , ...

(Date:5/25/2013)... Life science and analytical reagents are ... and create a new substance with the purpose of ... known as biotechnology reagents. Such reagents are significant in ... This market is driven by factors such as expansion ... therapeutics, growth in research and rapid commercialization of such ...

(Date:5/25/2013)... make great companions for senior citizens, but elderly people who ... more likely to crash than those who never drive with ... 2,000 licensed drivers aged 70 and older. The nearly 700 ... with their pet in the car. Among those who ... as high as among those who never drove with their ...

(Date:5/25/2013)... City Center, FL (PRWEB) May 25, 2013 ... is one of many of the NALA’s businesses throughout the ... Craig Amshel chose to participate in the nationwide event as ... as a Lieutenant Colonel in the Army. He said, “I ... in the community I serve, but I live here too.” ...

(Date:5/25/2013)... York, NY (PRWEB) May 25, 2013 ... dedicated to brain cancer research and advocacy, comments on ... Extraterrestrial Physics, that shows incorporating cold atmospheric plasma into ... cells. , According to a Science Daily ... Extraterrestrial Physics (MPE), biologists and physicians demonstrated the “synergistic ...

Breaking Medicine News(10 mins):Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2 Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3 Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4 Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2 Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3 Health News:Seniors More Likely to Crash When Driving With Pet: Study 2 Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2 Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2

[0] How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation [0] Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research [0] Seniors More Likely to Crash When Driving With Pet: Study [0] Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event [0] Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells

... Tenn. March 25, 2011) Ching-Hon Pui, M.D., a ... Children,s Research Hospital, is the recipient of the 2011 ... Clinical Research from the American Association for Cancer Research ... for Outstanding Achievement in Clinical Research is presented to ...

... ORLANDO, Fla. The American Association for Cancer Research ... contributed to progress in the fight against cancer at ... present an educational lecture at the meeting, which will ... Center. "We are honoring an exceptional group of ...

... Researchers at Mount Sinai School of Medicine have discovered ... may cause the most common inherited form of Parkinson,s ... journal Public Library of Science, shows that upon specific ... of proteins called 14-3-3, which has a regulatory function ...

... HealthDay Reporter , THURSDAY, March 24 (HealthDay News) ... and home-cooked foods rises, so, too, does body weight, ... 27 years. "Added sugars and body weight are ... the University of Minnesota School of Public Health, ...

... Jenifer Goodwin HealthDay Reporter , THURSDAY, March ... feeling of being at the park or the mall, ... parents of autistic children, those concerns can be even ... Alzheimer,s, autism experts say a tendency to wander is ...

... The ninth installment in the Berlin Open Access Conference ... funding, and policy communities around The Berlin Declaration on ... will take place at the Howard Hughes Medical Institute ... "Berlin 9 Open Access Conference: The impact of Open ...

Ching-Hon Pui, M.D., recognized with American Association for Cancer Research award AACR honors eminent researchers Mount Sinai finds promising clue to mechanism behind gene mutation that causes Parkinson's disease More Added Sugars, More Pounds?Dangerous Wandering a Lesser Known Side of Autism International Open Access meeting comes to the United States

... as thread-guide reducing time and trauma in ... is inserted into the nasolacrimal duct and ... it. The probe is then withdrawn leaving ... tubing in place. Canalicular Laceration or Imperforate ...

... prolene as thread-guide reducing time and trauma ... Probe is inserted into the nasolacrimal duct ... through it. The probe is then withdrawn ... silicone tubing in place. Newly coated with ...

For Canalicular Stenosis in Infants. Medical grade silicone. Note: Can also be used in DCR because of its high flexibility. Probe entirely embedded in silicone tubing (non-traumatic). Box of 3, steri...

For proper plug sizing....

Medicine Products:

Self-Threading MONOKA (Fayet-Bernard Ritleng Type, 3 mm COLLARETTE)Self-Threading MONOKA (Fayet-Bernard Ritleng Type, PVP coating)Infant Bika Punctal Gauges-Complete Set